Letter to the Editor Regarding "Dynamic Femur Fracture Brace Vs Hip Spica Cast for Pediatric Femoral Shaft Fractures: A Retrospective Comparative Cohort Study" Authors: Megan Hannon, Kristin Livingston, Amanda Baier, Audrey Cantillion Published: 2026 Dear Editor, We read with great interest the recent article by Casey et al., regarding the application of the DF2 brace for pediatric femoral shaft fractures in the August 2025 issue of JPOSNA®. As Dr. Casey highlighted, the existing literature remains limited. Previous studies suggest promising clinical effectiveness, and Dr. Casey's expanded experience reinforces that DF2 bracing offers reliable outcomes without significant adverse events. Our high volume academic level 1 trauma center has implemented the DF2 brace as part of our treatment algorithm for pediatric femur fractures. We have expanded indications beyond standard closed treatment of femur fractures and found success with pathologic fractures and postsurgical patients. Our institutional experience aligns with previously published work; we replaced a substantial proportion of traditional spica casts (placed in the operating room [OR]) with DF2 braces (placed in the emergency department [ED]). This change decreased OR and anesthesia utilization, fracture stabilization delays, and spica cast-related complications. We have also nearly eradicated the need for car-seat alternatives. However, implementation highlighted several key challenges that while not insurmountable, warrant consideration among centers pursuing broader adoption. As a large hospital with multiple clinical teams and practice settings, most implementation challenges have been logistical. First, dissemination of consistent DF2-specific education proved difficult due to the myriad providers (surgeons, APCs, and nurses) initially unfamiliar with the brace. Significant educational efforts were required to ensure safe, appropriate application and the comfort of providers and parents. Further, responsibility for repairs and adjustments had to be clearly delineated among physicians, orthotists, nurse practitioners, physician assistants, nurses and cast techs, which was convoluted due to scope-of-practice limitations and the availability of on-call providers. Skin complications were uncommon but notable. We encountered isolated instances of significant skin irritation, including one patient who required transition to a spica cast due to a severe rash. To mitigate the risk of skin concerns, we instituted a one-week postapplication skin check and sock change - while Casey standardized a two-week check in their article. Billing and reimbursement pathways are unprecedented at BCH and have been the primary challenge given the brace's unique nature. Complexities included which budget would purchase the braces (orthopaedics, the operating room, or the emergency department), how to bill across care locations (OR, inpatient unit, ED, or clinic, each with different billing mechanisms), and how to track inventory (currently managed manually via email). Payor reimbursement has been highly variable and may require further advocacy to improve coverage. Finally, while our anecdotal experience suggests that patients tolerate the DF2 brace well in the immediate postapplication period, formal data on pain, family coping, and satisfaction compared with traditional spica casting remain limited. These outcomes represent important opportunities for future study, which we are currently undertaking. In summary, we feel strongly that the DF2 brace represents a valuable advancement in pediatric femur fracture care. Our institution has experienced a dramatic shift in management patterns, with clear benefits and implementation challenges worthy of consideration. Further work examining pain, family satisfaction, optimal education strategies, and reimbursement pathways will help refine best practices and support broader adoption. Sincerely, Author contributions Megan Hannon: Conceptualization, Writing – original draft, Writing – review & editing. Kristin Livingston: Conceptualization, Writing – review & editing. Amanda Baier: Writing – review & editing. Audrey Cantillion: Writing – review & editing. Funding No funding. Declaration of competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.